Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)
St. Michael's Hospital · University of Toronto · +10 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
635
total citations
- FWCI
- 32.92
- Percentile
- 100%
- References
- 31
Citations per year
Authors
13Topics & keywords
Topics
Keywords
- Endothelin receptor antagonist
- Medicine
- Glasgow Outcome Scale
- Subarachnoid hemorrhage
- Placebo
- Endovascular coiling
- Clinical endpoint
- Vasospasm
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.